Event Summary
The 47th Annual General Meeting (AGM) of AstraZeneca Pharma India Limited was held on Monday, August 10, 2026 through Video Conferencing/Other Audio Visual Means.
The meeting was scheduled to commence at 3:00 PM but actually began at 3:18 PM due to lack of requisite quorum at the scheduled time. The AGM concluded at 5:20 PM.
Business Items Transacted
The following resolutions were approved at the AGM:
- Adoption of Financial Statements for the financial year ended March 31, 2026 along with Reports of the Board of Directors and Auditors
- Declaration of dividend of ₹36 per equity share
- Re-appointment of Ms. Bhavana Agrawal (DIN: 10485441) who retired by rotation
- Appointment of M/s. BSR & Co. LLP, Chartered Accountants (Firm Registration No. 101248W/W-00022) as Statutory Auditors of the Company
- Re-appointment of Ms. Shilpa Divekar Nirula as an Independent Director for a second term of five consecutive years from December 29, 2026 to December 28, 2031 (both days inclusive)
Voting Arrangements
The Company provided remote e-Voting facility to members from Thursday, August 6, 2026 at 9:00 AM (IST) to Sunday, August 9, 2026 at 5:00 PM (IST) for resolutions 1 to 5. Members who participated in the AGM through VC/OAVM facility and had not cast their votes through remote e-Voting were provided facility to e-Vote on the NSDL portal during the AGM.